相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Therapeutic Targets and Emerging Treatments in Advanced Chondrosarcoma
Shinji Miwa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Genetics and epigenetics in conventional chondrosarcoma with focus on non-coding RNAs
Albert Roessner et al.
PATHOLOGY RESEARCH AND PRACTICE (2022)
BMS-986158, a Small Molecule Inhibitor of the Bromodomain and Extraterminal Domain Proteins, in Patients with Selected Advanced Solid Tumors: Results from a Phase 1/2a Trial
John Hilton et al.
CANCERS (2022)
Modern epigenetics methods in biological research
Yuanyuan Li
METHODS (2021)
Hypomethylating Chemotherapeutic Agents as Therapy for Myelodysplastic Syndromes and Prevention of Acute Myeloid Leukemia
Vincent G. Sorrentino et al.
PHARMACEUTICALS (2021)
14-3-3 modulation of the inflammatory response
Claire C. Munier et al.
PHARMACOLOGICAL RESEARCH (2021)
Epigenetic Dysregulations in Merkel Cell Polyomavirus-Driven Merkel Cell Carcinoma
John Charles Rotondo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Stratifin in ocular surface squamous neoplasia and its association with p53
Sheetal Chauhan et al.
ACTA OPHTHALMOLOGICA (2021)
Epigenetic Regulation of MicroRNA Clusters and Families during Tumor Development
Jana Gregorova et al.
CANCERS (2021)
A phase 2 study of belinostat and SGI-110 (guadecitabine) for the treatment of unresectable and metastatic conventional chondrosarcoma.
Jay Oza et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Germinal epimutation of Fragile Histidine Triad (FHIT) gene is associated with progression to acute and chronic adult T-cell leukemia diseases
Marcia Bellon et al.
MOLECULAR CANCER (2021)
The role of long non-coding RNA BCAR4 in human cancers
Qiong Yi et al.
HUMAN CELL (2021)
Co-Treatment with the Epigenetic Drug, 3-Deazaneplanocin A (DZNep) and Cisplatin after DZNep Priming Enhances the Response to Platinum-Based Therapy in Chondrosarcomas
Eva Lhuissier et al.
CANCERS (2021)
SUMOylation Is Associated with Aggressive Behavior in Chondrosarcoma of Bone
Jessie S. Kroonen et al.
CANCERS (2021)
SOX2 in development and cancer biology
Daniel Novak et al.
SEMINARS IN CANCER BIOLOGY (2020)
Midkine (MDK) growth factor: a key player in cancer progression and a promising therapeutic target
Panagiota S. Filippou et al.
ONCOGENE (2020)
Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced Chondrosarcoma
William D. Tap et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Recent trends in targeting miRNAs for cancer therapy
Vandit Shah et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2020)
p73: From the p53 shadow to a major pharmacological target in anticancer therapy
Helena Ramos et al.
PHARMACOLOGICAL RESEARCH (2020)
Beyond the Influence of IDH Mutations: Exploring Epigenetic Vulnerabilities in Chondrosarcoma
Sanne Venneker et al.
CANCERS (2020)
RUNX3 regulates cell cycle-dependent chromatin dynamics by functioning as a pioneer factor of the restriction-point
Jung-Won Lee et al.
NATURE COMMUNICATIONS (2019)
DNA hypermethylation in disease: mechanisms and clinical relevance
Melanie Ehrlich
EPIGENETICS (2019)
Antiproliferative effect of the histone demethylase inhibitor GSK-J4 in chondrosarcomas
Eva Lhuissier et al.
IUBMB LIFE (2019)
Anti-miRNA Oligonucleotide Therapy for Chondrosarcoma
Xiaojuan Sun et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Integrated molecular characterization of chondrosarcoma reveals critical determinants of disease progression
Remy Nicolle et al.
NATURE COMMUNICATIONS (2019)
H3K27me3 deficiency defines a subset of dedifferentiated chondrosarcomas with characteristic clinicopathological features
Naohiro Makise et al.
MODERN PATHOLOGY (2019)
CDH1 (E-Cadherin) Mutation and Gastric Cancer: Genetics, Molecular Mechanisms and Guidelines for Management
Santosh Shenoy
CANCER MANAGEMENT AND RESEARCH (2019)
Novel Modes of Inhibition of Wild-Type Isocitrate Dehydrogenase 1 (IDH1): Direct Covalent Modification of His315
Clarissa G. Jakob et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer
T. Boulding et al.
SCIENTIFIC REPORTS (2018)
Cancer epigenetics: Moving forward
Angela Nebbioso et al.
PLOS GENETICS (2018)
Chondrosarcoma: An overview of clinical behavior, molecular mechanisms mediated drug resistance and potential therapeutic targets
Elahe Nazeri et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
Jacob O'Brien et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
DNA methylation profiles in cancer diagnosis and therapeutics
Yunbao Pan et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2018)
Long non-coding RNA BCAR4 promotes chondrosarcoma cell proliferation and migration through activation of mTOR signaling pathway
Xiaolong Shui et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2017)
NAD Synthesis Pathway Interference Is a Viable Therapeutic Strategy for Chondrosarcoma
Elisabeth F. P. Peterse et al.
MOLECULAR CANCER RESEARCH (2017)
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rajesha Rupaimoole et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Runx3 plays a critical role in restriction-point and defense against cellular transformation
X-Z Chi et al.
ONCOGENE (2017)
HDAC6 inhibition suppresses chondrosarcoma by restoring the expression of primary cilia
Wei Xiang et al.
ONCOLOGY REPORTS (2017)
Induction of sirtuin-1 signaling by resveratrol induces human chondrosarcoma cell apoptosis and exhibits antitumor activity
Sung-Chuan Chao et al.
SCIENTIFIC REPORTS (2017)
The expression of SIRT1 regulates the metastaticplasticity of chondrosarcoma cells by inducing epithelial-mesenchymal transition
Helin Feng et al.
SCIENTIFIC REPORTS (2017)
IDH1 or -2 mutations do not predict outcome and do not cause loss of 5-hydroxymethylcytosine or altered histone modifications in central chondrosarcomas
Arjen H. G. Cleven et al.
CLINICAL SARCOMA RESEARCH (2017)
LINE-1 in cancer: multifaceted functions and potential clinical implications
Lu Xiao-Jie et al.
GENETICS IN MEDICINE (2016)
Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage
Ansar Karimian et al.
DNA REPAIR (2016)
Role of TET enzymes in DNA methylation, development, and cancer
Kasper Dindler Rasmussen et al.
GENES & DEVELOPMENT (2016)
Malignant Peripheral Nerve Sheath Tumor
Aaron W. James et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2016)
Aberrant DNA methylations in chondrosarcoma
Pei Liu et al.
EPIGENOMICS (2016)
Effect of cytostatic proline rich polypeptide-1 on tumor suppressors of inflammation pathway signaling in chondrosarcoma
Karina Galoian et al.
MOLECULAR AND CLINICAL ONCOLOGY (2016)
DNA methylation of channel-related genes in cancers
Halima Ouadid-Ahidouch et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2015)
Transcription of tandemly repetitive DNA: functional roles
Maria Assunta Biscotti et al.
CHROMOSOME RESEARCH (2015)
miR-181a Targets RGS16 to Promote Chondrosarcoma Growth, Angiogenesis, and Metastasis
Xiaojuan Sun et al.
MOLECULAR CANCER RESEARCH (2015)
Restored expression levels of TET1 decrease the proliferation and migration of renal carcinoma cells
Min Fan et al.
MOLECULAR MEDICINE REPORTS (2015)
Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells
Luyuan Li et al.
PLOS ONE (2015)
Mutant IDH1 Dysregulates the Differentiation of Mesenchymal Stem Cells in Association with Gene-Specific Histone Modifications to Cartilage- and Bone-Related Genes
Yonghui Jin et al.
PLOS ONE (2015)
The oncometabolite D-2-hydroxyglutarate induced by mutant IDH1 or-2 blocks osteoblast differentiation in vitro and in vivo
Johnny Suijker et al.
ONCOTARGET (2015)
Inhibition of mutant IDH1 decreases D-2-HG levels without affecting tumorigenic properties of chondrosarcoma cell lines
Johnny Suijker et al.
ONCOTARGET (2015)
Deacetylation of α-tubulin and cortactin is required for HDAC6 to trigger ciliary disassembly
Jie Ran et al.
SCIENTIFIC REPORTS (2015)
Gallic acid induces apoptosis and inhibits cell migration by upregulating miR-518b in SW1353 human chondrosarcoma cells
Wenna Liang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
TET1 Exerts Its Tumor Suppressor Function by Interacting with p53-EZH2 Pathway in Gastric Cancer
Hua-Lin Fu et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2014)
Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia
Panagiotis Ntziachristos et al.
NATURE (2014)
Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma
Rintaro Hashizume et al.
NATURE MEDICINE (2014)
3-Deazaneplanocin A (DZNep), an Inhibitor of the Histone Methyltransferase EZH2, Induces Apoptosis and Reduces Cell Migration in Chondrosarcoma Cells
Nicolas Girard et al.
PLOS ONE (2014)
Regulation of onco and tumor suppressor MiRNAs by mTORC1 inhibitor PRP-1 in human chondrosarcoma
Karina A. Galoian et al.
TUMOR BIOLOGY (2014)
SOCS3, a major regulato of infection and inflammation
Bent Carow et al.
FRONTIERS IN IMMUNOLOGY (2014)
Sumoylation: A Regulatory Protein Modification in Health and Disease
Annette Flotho et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 82 (2013)
IDH1 and IDH2 Mutations in Gliomas
Adam L. Cohen et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2013)
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
Julie-Aurore Losman et al.
GENES & DEVELOPMENT (2013)
Molecular mechanisms of the cartilage-specific microRNA-140 in osteoarthritis
Rui Zhang et al.
INFLAMMATION RESEARCH (2013)
Loss of RUNX3 expression may contribute to poor prognosis in patients with chondrosarcoma
Zhe Jin et al.
JOURNAL OF MOLECULAR HISTOLOGY (2013)
Analysis of MicroRNAs Expressions in Chondrosarcoma
Teruhito Yoshitaka et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2013)
Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma
Patrick S. Tarpey et al.
NATURE GENETICS (2013)
DNA Methylation and Its Basic Function
Lisa D. Moore et al.
NEUROPSYCHOPHARMACOLOGY (2013)
HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis
Miao Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2
Paul Guilhamon et al.
NATURE COMMUNICATIONS (2013)
Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosarcoma, Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma
Idriss M. Bennani-Baiti et al.
HUMAN PATHOLOGY (2012)
3-Deazaneplanocin A is a promising therapeutic agent for the eradication of tumor-initiating hepatocellular carcinoma cells
Tetsuhiro Chiba et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Histone Lysine Methylation Dynamics: Establishment, Regulation, and Biological Impact
Joshua C. Black et al.
MOLECULAR CELL (2012)
Frequent Mutation of Isocitrate Dehydrogenase (IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping
Darrell R. Borger et al.
ONCOLOGIST (2012)
S-adenosylhomocysteine hydrolase inhibition by 3-deazaneplanocin A analogues induces anti-cancer effects in breast cancer cell lines and synergy with both histone deacetylase and HER2 inhibition
Annette Hayden et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
The meaning of p16ink4a expression in tumors Functional significance, clinical associations and future developments
Agnieszka K. Witkiewicz et al.
CELL CYCLE (2011)
IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours
M. Fernanda Amary et al.
JOURNAL OF PATHOLOGY (2011)
Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition
Oliver G. McDonald et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
Epigenetic and epigenomic mechanisms shape sarcoma and other mesenchymal tumor pathogenesis
Idriss M. Bennani-Baiti
EPIGENOMICS (2011)
Anti-chondrosarcoma effects of PEDF mediated via molecules important to apoptosis, cell cycling, adhesion and invasion
Mei Lin Tan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Microenvironment alters epigenetic and gene expression profiles in Swarm rat chondrosarcoma tumors
Christopher A. Hamm et al.
BMC CANCER (2010)
Epigenetics: methylation-associated repression of heparan sulfate 3-O-sulfotransferase gene expression contributes to the invasive phenotype of H-EMC-SS chondrosarcoma cells
Catherine Bui et al.
FASEB JOURNAL (2010)
Histone Demethylase LSD1 Regulates Neural Stem Cell Proliferation
GuoQiang Sun et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Dynamical effects of epigenetic silencing of 14-3-3 sigma expression
Julio Vera et al.
MOLECULAR BIOSYSTEMS (2010)
Satellite DNA in the Karyotype Evolution of Domestic - Animals Clinical Considerations
F. Adega et al.
CYTOGENETIC AND GENOME RESEARCH (2009)
SOCS3 as a tumor suppressor in breast cancer cells, and its regulation by PRL
Johanna L. Barclay et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation
Tina Branscombe Miranda et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Lenny Dang et al.
NATURE (2009)
Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome
Elaine R. Mardis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth
Y. H. Zhao et al.
ONCOGENE (2009)
Global Demethylation of Rat Chondrosarcoma Cells after Treatment with 5-Aza-2′-Deoxycytidine Results in Increased Tumorigenicity
Christopher A. Hamm et al.
PLOS ONE (2009)
Roles of the EZH2 histone methyltransferase in cancer epigenetics
Jeffrey A. Simon et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2008)
HIV-I Vif, APOBEC, and intrinsic immunity
Ritu Goila-Gaur et al.
RETROVIROLOGY (2008)
HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions
Agustin Valenzuela-Fernandez et al.
TRENDS IN CELL BIOLOGY (2008)
Pharmacologic disruption of polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells
Jing Tan et al.
GENES & DEVELOPMENT (2007)
Heparan sulphate proteoglycans fine-tune mammalian physiology
Joseph R. Bishop et al.
NATURE (2007)
Genetic unmasking of an epigenetically silenced microRNA in human cancer cells
Amaia Lujambio et al.
CANCER RESEARCH (2007)
The effects of histone deacetylase inhibitors on the induction of differentiation in chondrosarcoma cells
Riku Sakimura et al.
CLINICAL CANCER RESEARCH (2007)
Peripheral chondrosarcoma progression is accompanied by decreased Indian Hedgehog signalling
L. Hameetman et al.
JOURNAL OF PATHOLOGY (2006)
RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer
Quek Choon Lau et al.
CANCER RESEARCH (2006)
p73, a sophisticated p53 family member in the cancer world
T Ozaki et al.
CANCER SCIENCE (2005)
Histone deacetylase inhibitors: A review of their clinical status as antineoplastic agents
G Garcia-Manero et al.
CANCER INVESTIGATION (2005)
Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies
JPJ Issa et al.
BLOOD (2004)
The microRNA Registry
S Griffiths-Jones
NUCLEIC ACIDS RESEARCH (2004)
Genetic and epigenetic alterations in tumor progression in a dedifferentiated chondrosarcoma
M Ropke et al.
PATHOLOGY RESEARCH AND PRACTICE (2003)
分享论文
